The encyclopedia · Product & Design · Operational decision · 2025
Hema's 'antibiotic-free' eggs carried a banned drug — premium brand's quality black box
A cockroach in X-store wontons, then eggs with a banned veterinary drug 55% over the limit — regulators opened cases while Hema offered refunds.
Hema (盒马) · 2025-05-08
What happened
In February 2025, a Shanghai consumer chewing through shepherd's-purse-and-pork wontons from a Hema X member store found a whole cockroach inside; the maker was Wuxi Shangqinghe Food. Shanghai regulators filed a case and sent an assistance-investigation letter to the manufacturer, with Wuxi authorities joining in. Hema sent staff to offer a refund, was called perfunctory for trying to push responsibility onto the manufacturer, and still answered 'negotiation in progress' after regulators had stepped in. The consumer's demands for ten-times compensation and damages remained unresolved.
In May 2025 the regulatory notices stacked up. Shandong's 'you point, we inspect' sampling found that 'antibiotic-free' eggs sold by Hema contained dimetridazole — a banned veterinary drug — at 55% over the limit and trimethoprim at 30% over; the supplier claimed its own retests passed, while Hema had missed filing its re-inspection application. In Nanjing, Hema's ready-to-eat kiwifruit was found 70% over the limit for the swelling agent forchlorfenuron. The products that failed were the ones carrying premium labels — 'antibiotic-free', 'premium', 'ready-to-eat'.
The pattern put a premiumization push ahead of the quality system. Hema's answers stuck to 'verifying with the supplier' and 'handling customer complaints', with no traceability results disclosed — the same reflex as 2024, when its X member stores were repeatedly exposed selling counterfeit name-brand cosmetics and Hema offered refunds but refused triple compensation. Analysts put it bluntly: the 30-minute delivery efficiency myth had collided with a quality black box. A brand that sells trust as the product cannot outsource the proof of it to supplier reports.
Why it happened
- Premium labels were sold faster than quality could back them: 'antibiotic-free' eggs carried a banned drug at 55% over the limit, and the supplier's self-inspection stood in for proof.
- The response template made it worse — refunds offered, blame pushed to manufacturers, traceability undisclosed — while regulators filed cases and Hema said 'negotiation in progress.'
- Scale-first expansion left upstream traceability unbuilt: a long-tail fresh supply chain audited through supplier reports alone is a risk system waiting for a sampling notice.
The lesson
Premium pricing is a quality promise. Hema sold 'antibiotic-free' eggs carrying a banned drug and wontons with a cockroach inside — refunds can't close a case that regulators have opened.
Aftermath
The structural flaw named in the ESG analysis: fresh retail's long-tail supply chain can't be controlled by supplier reports alone, and the quality system must upgrade in step with premium labels — otherwise every 'concept' product becomes a sampling target. Hema's inspection notices kept accumulating through the summer of 2025. Whether 30-minute delivery can coexist with a quality black box is the question regulators keep answering for it.
Sources
- Sina Finance ESG — Hema's food safety problems keep getting named: how to cross the transition period, 2025-05-20
- NetEase — Hema under case investigation: when trust collapses, who pays for consumers' sense of safety, 2025-03-03
spotted an error? The club wants to know.
More like this
Lao Gan Ma: the chili sauce that killed the noodle shop
OVENSTAR's Ningbo push broke cash flow, shuttering stores and leaving wages owed
From ¥10B to its first loss: VATS met the baijiu winter
Somewhere, someone solved the problem this company failed at. 2nd Opinion →

Comments · 0
Sign in to join the comments.